SEC Form 4 · accession 0001209191-18-061348
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A. DesJardin
Officer — EVP, Technical Operations
Period of report
Dec 5, 2018
Accepted (ET)
Dec 6, 2018 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Dec 5, 2018 | M | 5,861 | — | A | 13,610 | D | |
| Ordinary SharesF3 | Dec 5, 2018 | F | 2,027 | $20.25 | D | 11,583 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F4 | — | Dec 5, 2018 | M | 5,861 | D | — | — | Ordinary Shares | 5,861 | 11,722 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 1,950 ordinary shares of the Issuer acquired by the reporting person on June 1, 2018 and 421 ordinary shares of the Issuer acquired on November 30, 2018, pursuant to an employee stock purchase program.
- F3Reflects the net settlement of ordinary shares of the Issuer in connection with the vesting of restricted stock units.
- F4On December 15, 2016, the reporting person was granted 23,443 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the vesting commencement date of December 5, 2016.